Zinc and COVID-19 : Immunity, Susceptibility, Severity and Intervention
During the coronavirus disease 2019 (COVID-19) pandemic and continuing emergence of viral mutants, there has been a lack of effective treatment methods. Zinc maintains immune function, with direct and indirect antiviral activities. Zinc nutritional status is a critical factor in antiviral immune responses. Importantly, COVID-19 and zinc deficiency overlap in high-risk population. Hence, the potential effect of zinc as a preventive and adjunct therapy for COVID-19 is intriguing. Here, this review summarizes the immune and antiviral function of zinc, the relationship between zinc levels, susceptibility, and severity of COVID-19, and the effect of zinc supplementation on COVID-19. Existing studies have confirmed that zinc deficiency was associated with COVID-19 susceptibility and severity. Zinc supplementation plays a potentially protective role in enhancing immunity, decreasing susceptibility, shortening illness duration, and reducing the severity of COVID-19. We recommend that zinc levels should be monitored, particularly in COVID-19 patients, and zinc as a preventive and adjunct therapy for COVID-19 should be considered for groups at risk of zinc deficiency to reduce susceptibility and disease severity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
---|---|
Enthalten in: |
Critical reviews in food science and nutrition - 64(2024), 7 vom: 19., Seite 1969-1987 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Fan [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 20.02.2024 Date Revised 20.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/10408398.2022.2119932 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM346114136 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM346114136 | ||
003 | DE-627 | ||
005 | 20240220232129.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10408398.2022.2119932 |2 doi | |
028 | 5 | 2 | |a pubmed24n1300.xml |
035 | |a (DE-627)NLM346114136 | ||
035 | |a (NLM)36094452 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Fan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Zinc and COVID-19 |b Immunity, Susceptibility, Severity and Intervention |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.02.2024 | ||
500 | |a Date Revised 20.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a During the coronavirus disease 2019 (COVID-19) pandemic and continuing emergence of viral mutants, there has been a lack of effective treatment methods. Zinc maintains immune function, with direct and indirect antiviral activities. Zinc nutritional status is a critical factor in antiviral immune responses. Importantly, COVID-19 and zinc deficiency overlap in high-risk population. Hence, the potential effect of zinc as a preventive and adjunct therapy for COVID-19 is intriguing. Here, this review summarizes the immune and antiviral function of zinc, the relationship between zinc levels, susceptibility, and severity of COVID-19, and the effect of zinc supplementation on COVID-19. Existing studies have confirmed that zinc deficiency was associated with COVID-19 susceptibility and severity. Zinc supplementation plays a potentially protective role in enhancing immunity, decreasing susceptibility, shortening illness duration, and reducing the severity of COVID-19. We recommend that zinc levels should be monitored, particularly in COVID-19 patients, and zinc as a preventive and adjunct therapy for COVID-19 should be considered for groups at risk of zinc deficiency to reduce susceptibility and disease severity | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a immunity | |
650 | 4 | |a zinc | |
650 | 4 | |a zinc deficiency | |
650 | 4 | |a zinc supplementation | |
650 | 7 | |a Zinc |2 NLM | |
650 | 7 | |a J41CSQ7QDS |2 NLM | |
700 | 1 | |a Zhong, Jiayi |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Rui |e verfasserin |4 aut | |
700 | 1 | |a Sun, Yongzhi |e verfasserin |4 aut | |
700 | 1 | |a Dong, Yingran |e verfasserin |4 aut | |
700 | 1 | |a Wang, Maoqing |e verfasserin |4 aut | |
700 | 1 | |a Sun, Changhao |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Critical reviews in food science and nutrition |d 1980 |g 64(2024), 7 vom: 19., Seite 1969-1987 |w (DE-627)NLM012713538 |x 1549-7852 |7 nnns |
773 | 1 | 8 | |g volume:64 |g year:2024 |g number:7 |g day:19 |g pages:1969-1987 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/10408398.2022.2119932 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 64 |j 2024 |e 7 |b 19 |h 1969-1987 |